Oticon Introduces Oticon More

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

January 12, 2021

Oticon, Inc. is challenging the conventions of hearing aid technology once again. The company today launched Oticon More ™, the first-ever hearing aid built with an on-board deep neural network, to give people with mild-to-severe hearing loss a fuller, more balanced and more effortless hearing experience.

The DNN in Oticon More is trained on 12 million real-life sounds to give the brain more of the information it needs to decipher the intricate details of sound. Based on this extensive experiential learning – not on a limited set of man-made rules – it processes speech in noise more like the human brain. This results in a more natural representation of sounds that improves wearers’ speech understanding, reduces listening effort and enables people with hearing loss to remember more of what is being said, even in noisy environments.

“With Oticon More, wearers receive a more natural representation of all sounds,” says Donald Schum, Ph.D., Vice President of Audiology, Oticon, Inc. “The DNN in Oticon More has learned the way the brain learns, naturally over time. Every sound that passes through the hearing aid is compared to the results discovered in the learning phase. This enables Oticon More to provide a more natural, full and precisely balanced sound scene, making it easier for the brain to perform optimally.”

Powerful, more intelligent sound processing

Oticon More with BrainHearing™ technology delivers what the brain needs to make better sense of sound. Built on Oticon’s most intelligent platform yet, Oticon More provides 30% more sound to the brain and improves speech understanding by 15%.*

Industry-leading innovation in sound processing technology ensures Oticon More delivers the information wearers need to decipher sounds and fully engage in any conversation. The hearing aid scans and analyzes the sound scene 500 times per second, capturing and processing the intricate details of sound with better contrast, balance and clarity than ever before.

Oticon More builds on Oticon’s legacy of award-winning product innovation and industry firsts. The hearing aid was recently named a CES® 2021 Innovation Awards Honoree in the Health & Wellness and Wearable Technologies categories.

Connectivity and convenience

Oticon More offers a wide range of connectivity options for a high-quality listening experience in everyday situations. The hearing aid supports direct streaming from iPhone® and select Android™ devices. For people who want the convenience of rechargeable batteries, Oticon More comes in a discreet lithium-ion based rechargeable style (miniRITE R) that provides a full day of battery life**, including streaming, after just three hours of charging.

The new hearing solution is built for individuals with mild-to-severe hearing loss. Wearers can select from eight attractive colors to blend with hair or skin tones.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.